Stay up-to-date
Follow us on social media
Latest news
Grifols pioneers high-tech analysis of plasma bank to detect early signs of Parkinson’s disease
Grifols submits Biologics License Application for its new fibrinogen solution to U.S. FDA
Grifols announces topline phase 3 data on long-term Albutein® (albumin [human] U.S.P.) therapy for decompensated cirrhosis with ascites
Media contacts
Journalist or media professional?
Our media relations team can be reached at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.
Not a journalist?
For general questions and requests, please contact corporatecomms@grifols.com.
Press Releases
Stay up-to-date on corporate developments as well as innovations in our plasma-derived medicines and other products and solutions.
Company Statements
Our official position on important matters.